美股新聞 標題聯播 · 近 24 小時 283 則 · 25 個來源 · 最新 9/20 07:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · SINT近 30 天 2 則 · 第 1 / 1 頁
- SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
- SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade
- SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement
- Sintx Technologies, Inc. Q2 2026 Earnings Call Summary
- SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights: Revenue Surges 199% as ...
- SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
- ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
- AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates
- SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast
- SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program
- SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
- Sintx Technologies Insiders Placed Bullish Bets Worth US$644.2k
- SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- SINTX Technologies to Present at the LD Micro Invitational XVI Conference
- Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates
- Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
- Artivion (AORT) Q1 Earnings and Revenues Surpass Estimates
- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。